A detailed history of D. E. Shaw & Co., Inc. transactions in Haleon PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 405,517 shares of HLN stock, worth $3.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
405,517
Holding current value
$3.81 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.32 - $10.7 $1.7 Million - $2.19 Million
204,875 Added 102.11%
405,517 $4.29 Million
Q2 2024

Aug 14, 2024

SELL
$8.01 - $8.64 $2.53 Million - $2.73 Million
-316,371 Reduced 61.19%
200,642 $1.66 Million
Q1 2024

May 15, 2024

BUY
$8.02 - $8.67 $4.15 Million - $4.48 Million
517,013 New
517,013 $4.39 Million
Q2 2023

Aug 14, 2023

BUY
$8.04 - $9.0 $537,594 - $601,785
66,865 New
66,865 $560,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $535,267 - $723,868
89,810 Added 195.63%
135,717 $1.09 Million
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $258,456 - $344,302
45,907 New
45,907 $279,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.